In the second episode of Pharm So Hard, Jimmy Pruitt, Pharm.D and Gary Peksa PharmD, BCPS discuss the pharmacology and reviews the management of hemorrhage caused by factor Xa inhibitors using coagulation factor Xa (recombinant), inactivated-zhzo or ANDEXXA.